Pooja Hariharan

This paper demonstrates that using affinity cocktails of antibody-radioconjugates improves tumor irradiation by combining high- and low-affinity variants to target different tumor regions, leading to better treatment outcomes.

This study evaluates dendrimer-radioconjugates with Actinium-225 and low-dose cisplatin for treating metastatic triple negative breast cancer across different anatomical sites in mice, showing improved survival without long-term toxicity.

This study shows that systemic actinium-225 dendrimer-radioconjugates improve glioblastoma survival in mice, with enhanced efficacy when combined with temozolomide.